KLK3 and posterior cortical atrophy: Changes in PSA values during treatment constitute one of themost used measures to study outcome in PCa patients, but the isolated measure of thisparameter has been shown not to be of prognostic value when corrected by BSI in patientswith CRPC who are undergoing chemotherapy [8].